Watch-and-wait policyversusrituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma-Reference-Cited by-同舟云学术

Watch-and-wait policyversusrituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma

Published:2018-03-25 Issue:8 Volume:33 Page:1461-1468
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Tari Akira¹,Kitadai Yasuhiko²,Mouri Ritsuo¹,Takigawa Hidehiko³,Asaoku Hideki⁴,Mihara Keiichiro⁵,Takata Katsuyoshi⁶,Fujihara Megumu⁷,Yoshino Tadashi⁶,Koga Tadashi⁸,Fujimori Shunji⁹,Tanaka Shinji¹⁰,Chayama Kazuaki³

Affiliation:

1. Division of Gastroenterology, Department of Internal Medicine; Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital; Hiroshima Japan

2. Department of Health and Science; Prefectural University of Hiroshima; Hiroshima Japan

3. Department of Gastroenterology and Metabolism; Hiroshima University; Hiroshima Japan

4. Department of Hematology; Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital; Hiroshima Japan

5. Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine; Hiroshima University; Hiroshima Japan

6. Department of Pathology; Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences; Okayama Japan

7. Department of Pathology; Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital; Hiroshima Japan

8. Shin Nippon Biomedical Laboratories, Ltd.; Kagoshima Japan

9. Department of Gastroenterology; Chiba Hokusou Hospital, Nippon Medical School; Chiba Japan

10. Department of Endoscopy and Medicine, Graduate School of Biomedical and Health Science; Hiroshima University; Hiroshima Japan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.14100/fullpdf

Reference31 articles.

1. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced- stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group;Hiddemann;Blood,2005

2. New treatment options have changed the survival of patients with follicular lymphoma;Fisher;J. Clin. Oncol.,2005

3. Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis;Schulz;J. Natl. Cancer Inst.,2007

4. Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma;Marcus;J. Clin. Oncol.,2008

5. Improved survival in patients with early stage low-grade follicular lymphoma treated with radiation: a Surveillance, Epidemiology, and End Results database analysis;Pugh;Cancer,2010

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics and outcomes of Brazilian patients with duodenal-type follicular lymphoma: a multicenter retrospective study;Leukemia & Lymphoma;2024-09-10

2. Duodenal-type follicular lymphoma: comprehensive insights into disease characteristics and established treatment strategies;Current Opinion in Oncology;2024-08-23

3. Duodenal-type follicular lymphoma: Report of four cases and review of the literature;World Chinese Journal of Digestology;2024-07-28

4. Recent updates on treatment options for primary follicular lymphoma of the gastrointestinal tract;Expert Review of Gastroenterology & Hepatology;2024-07-02

5. Incidental Finding of a Duodenal-Type Follicular Lymphoma in Metabolic Dysfunction-Associated Steatohepatitis Cirrhosis: A Rare Malignancy With Favorable Outcomes;ACG Case Reports Journal;2024-05